R R

What Is Nephrogenic Systemic Fibrosis (Ocular Signs)?

Nephrogenic systemic fibrosis is a rare fibrosing disorder seen in people with advanced kidney failure, and ocular signs reflect fibrosis and inflammation around the eyes. The condition has been linked to exposure to some gadolinium based contrast agents during imaging. In the eye region, patients can develop tight, thickened periocular skin, lid retraction, and discomfort. Conjunctival injection, chemosis, or subconjunctival plaques are sometimes noted. These changes accompany more widespread skin and systemic fibrosis.

Link to This Resource Page

Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.

To display this...

What Is Nephrogenic Systemic Fibrosis (Ocular Signs)?

Nephrogenic systemic fibrosis is a rare fibrosing disorder seen in people with advanced kidney failure, and ocular signs reflect fibrosis and inflammation around the eyes. The condition has been linked to exposure to some gadolinium based contrast agents during imaging. In the eye region, patients can develop tight, thickened periocular skin, lid retraction, and discomfort. Conjunctival injection, chemosis, or subconjunctival plaques are sometimes noted. These changes accompany more widespread skin and systemic fibrosis.

read more about nephrogenic systemic fibrosis ocular signs ...

Copy this HTML:

Copy HTML Copied!

Systemic Disease and Risk Factors

NSF occurs mainly in patients with severe chronic kidney disease or those on dialysis who were exposed to certain gadolinium agents. Impaired renal clearance allows gadolinium to persist and trigger abnormal fibroblast activation in susceptible individuals. The skin of the limbs and trunk becomes thickened, woody, and bound down, and joint contractures limit movement. Internal organs can also be affected. Ocular involvement is part of this broader fibrosing process rather than an isolated eye condition.

Ocular Manifestations and Examination

Periocular skin may look tight, shiny, and indurated, with reduced eyelid mobility and incomplete closure in advanced cases. Some patients show lid retraction or lagophthalmos that exposes the cornea, leading to dryness and irritation. Conjunctival vessels can be prominent, and focal yellow white subconjunctival or scleral plaques are reported. Extraocular movement can be mildly restricted when fibrosis involves deeper tissues. The optic nerve and retina are usually normal, but chronic exposure and surface disease can reduce comfort and visual quality.

Diagnosis and Evaluation

Diagnosis of NSF is based mainly on systemic findings and skin biopsy showing increased collagen and fibrocyte proliferation. The history of severe renal impairment and gadolinium exposure is central. Ophthalmic assessment documents periocular skin changes, eyelid function, and ocular surface health. Corneal staining and tear film tests evaluate exposure or dryness. Coordination with nephrology and dermatology helps confirm the diagnosis and rule out mimicking conditions such as scleroderma or pretibial myxedema.

Management and Eye Care

There is no single cure for NSF, so management focuses on preventing further gadolinium exposure, supporting kidney health, and protecting affected tissues. For the eyes, aggressive lubrication, moisture goggles, and lid taping at night can protect the cornea when closure is incomplete. In some cases, tarsorrhaphy or lid surgery is considered to shield the surface. Systemic treatments such as improved dialysis regimens or immunomodulatory therapies are guided by nephrology and rheumatology. Early recognition of ocular signs helps prevent corneal damage.

FAQs About NSF and the Eyes

Can nephrogenic systemic fibrosis start in the eyes?

No, it is a systemic condition, and ocular signs appear along with or after skin and joint changes.

Are all gadolinium scans dangerous for the eyes?

Risk is highest in people with severe kidney failure exposed to certain contrast agents; modern practice uses safer agents and screening.

Can eye symptoms from NSF be reversed?

Some irritation improves with surface protection, but fixed skin tightening and fibrosis can be difficult to reverse.

How can patients with kidney disease reduce NSF risk?

Discuss contrast choices with doctors, avoid unnecessary gadolinium studies, and keep nephrology involved in imaging decisions.

References

Mayo Clinic. ?Nephrogenic systemic fibrosis - Symptoms and causes.? https://www.mayoclinic.org/diseases-conditions/nephrogenic-systemic-fibrosis/symptoms-causes/syc-20376005

NCBI Bookshelf (StatPearls). ?Nephrogenic Systemic Fibrosis.? https://www.ncbi.nlm.nih.gov/books/NBK567754/

U.S. FDA. ?Gadolinium-based Contrast Agents (GBCAs) and Nephrogenic Systemic Fibrosis (NSF).? https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/gadolinium-based-contrast-agents-gbcas-and-nephrogenic-systemic-fibrosis-nsf

Cleveland Clinic. ?Nephrogenic Systemic Fibrosis (NSF).? https://my.clevelandclinic.org/health/diseases/17783-nephrogenic-systemic-fibrosis-nsf

NORD. ?Nephrogenic Systemic Fibrosis.? https://rarediseases.org/rare-diseases/nephrogenic-systemic-fibrosis/